Screening rates are highest (46.6%) with extra patient contact in addition to a phone reminder and home self-collection kit.

DGX stock rises on a new partnership with MD Anderson to develop a blood test targeting multiple cancer risks.

Quest plans to refine, develop and validate the technology and is aiming to launch the test in North America next year.

Quest Diagnostics will work on a blood test for cancer risk it says may help identify people who could benefit from more ...

Giving patients more direct control over their healthcare data is a frequent talking point among healthcare leaders. | The ...

The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital are collaborating to launch the Kinder ...

You may have heard that moderate intensity exercise — even brisk walking — may be linked to a 37 percent reduction in risk of ...

Platform aims to simplify and improve patient consent process to strengthen future initiativesHOUSTON and SAN FRANCISCO, June 09, 2025 (GLO ...

Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert ...

Historically, the gold standard for diagnosing colorectal cancer has been a colonoscopy. During the procedure, a thin tube ...

BRYAN, Texas (KBTX) - With his family alongside, Roy Lopez toured his brand-new home Friday evening, about 24 hours after learning he was the 2025 Bryan/College Station St. Jude Dream Home winner. He ...

Mail-in self-collection tests for human papillomavirus (HPV) more than doubled cervical cancer screening participation among ...